David Tadevosian I Shutterstock.com
With highly pathogenic avian influenza (HPAI) once again disrupting markets around the world and now jumping into multiple species, Peter Halfmann believes it's time for a new approach.
FDA's veterinary innovation grant takes aim at HPAI
The grant's recipients will focus on using genetic engineering to stop the spread of a disease where they say vaccines have largely failed.